Navigation Links
SCAI Statement on the Hospitalization of Former President Bill Clinton
Date:2/12/2010

WASHINGTON, Feb. 12 /PRNewswire/ -- Members of the interventional cardiology community wish former President Bill Clinton a quick recovery following his recent hospitalization for angioplasty and stenting.

Like many heart patients, Mr. Clinton has communicated a desire to return to work promptly. Because angioplasty procedures are performed percutaneously, without major surgery to open the chest, most patients who receive coronary stents leave the hospital within one to two days and promptly return to the activities they love. 

News of Mr. Clinton's treatment serves as a reminder of the importance of utilizing the full range of medical and device treatments for patients with heart disease. Medication, angioplasty, stents and bypass surgery all play a key role – often complementing one another – in treating and saving thousands of heart patients' lives each year. Like Mr. Clinton, many patients taking the appropriate prescribed medications find that additional treatment may be needed to reduce debilitating symptoms like chest pain.

Mr. Clinton's experience also demonstrates how important it is for patients to listen to their body's warning signals. Mr. Clinton's quick response to his symptoms led to prompt and effective care and may have prevented a much more serious incident. All cardiac patients should be aware that heart disease is chronic – that the disease often progresses even after successful revascularization procedures such as bypass surgery, which Mr. Clinton underwent six years ago. Drug-eluting stents, now commonly used for percutaneous procedures, have further reduced the risk of needing another procedure compared to older stent technology.

Cardiovascular disease remains the leading killer of both men and women in America. It is only through continued innovation and access to the full range of treatment options that we can effectively battle cardiovascular disease for all patients – those who are at risk, those who suffer from stable chest pain, and those who experience heart attack.

About SCAI

Headquartered in Washington, D.C., the Society for Cardiovascular Angiography and Interventions is a 4,000-member professional organization representing invasive and interventional cardiologists in more than 60 nations. SCAI's mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's patient and physician education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit www.scai.org or www.seconds-count.org.

SOURCE SCAI

RELATED LINKS
http://www.scai.org
http://www.seconds-count.org

'/>"/>

SOURCE SCAI
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
2. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
4. Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse
5. Sinovac Files Shelf Registration Statement
6. Derma Sciences Files S-1 Registration Statement
7. Neuro Kinetics Statement Concerning Newspaper Article
8. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
9. Statement of Americas Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
10. Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
11. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners is ... sequencing and genomics experience, as Vice President of North American Capital Sales at ... for leading the sales team in the commercialization of the HTG EdgeSeq system and ...
Breaking Medicine News(10 mins):